Thursday, January 11, 2007 2:06:32 PM
RANCHO CORDOVA, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural heart diseases, said today that it expects fiscal 2006 revenues to be approximately $103 million and revenues for the fourth quarter of 2006 to be approximately $29 million. This compares with prior revenue guidance given on November 1, 2006 for fiscal 2006 revenues of $98 million. These results reflect year-over-year revenue growth of approximately 12 percent and 20 percent for the full year and fourth quarter of 2006, respectively.
The company said that it was providing the updated 2006 revenue projection in advance of company meetings with the investment community and a presentation at the JP Morgan Healthcare Conference on Thursday, January 11. Further details of the company's fourth quarter and full-year operating and financial performance will be released later this quarter, which will be followed by a conference call and web cast open to all interested parties. Details of the earnings release date, conference call and web cast will be provided in a subsequent release.
As previously announced, Scott Huennekens, president and chief executive officer, will be speaking about the company at the JP Morgan Healthcare Conference, beginning tomorrow at 8 a.m., Pacific Standard Time (11 a.m., Eastern Standard Time). The presentation will be available through https://events.jpmorgan.com and via the company's website at www.volcanocorp.com.
Volcano Corporation offers a broad suite of devices that facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart diseases and guide optimal therapies. The company's intravascular (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab and single-use phased array and rotational IVUS imaging catheters. Volcano also has unique advanced functionality options such as VH tissue characterization and IVUS and angiography co-registration. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires. Currently, more than 2,300 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at www.volcanocorp.com
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM